{"disease":{"id":"neuropathy-demyelinating","name":"neuropathy demyelinating"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07333196","title":"Tongji NADs Cohort","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1550,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT06859099","title":"Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":300,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT05327114","title":"Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":201,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT06968975","title":"Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT07091630","title":"A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"argenx","has_results":false},{"nct_id":"NCT06290128","title":"A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT02027701","title":"Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"CSL Behring","has_results":true},{"nct_id":"NCT04154540","title":"Posturography-Neuropathy","phase":"NA","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT03275740","title":"A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":58,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT06325943","title":"Rituximab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Istituto Clinico Humanitas","has_results":false},{"nct_id":"NCT03008733","title":"Descriptive Analysis of Morphological Aspects of Nerve by Ultra-high Frequency Ultrasound (30-50MHZ) in Demyelinating Neuropathies: Inflammatory Demyelinating Polyneuropathy Chronic (IPDC), Neuropathy Multifocal Motor Block of Conducting (NMMBC) and Neuropathy With Antibody A MAG","phase":"NA","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nice","has_results":false},{"nct_id":"NCT03268161","title":"Prevalence of Genetic Mutations in Patients With Neuropathy Associated With Anti-Myelin-associated Glycoprotein (MAG) Antibodies","phase":"","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT05877040","title":"A Proof of Concept Study With Rituximab in Patients With CIDP Not Responding to Conventional Immune Therapy","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Istituto Clinico Humanitas","has_results":false},{"nct_id":"NCT04356781","title":"Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Walton Centre NHS Foundation Trust","has_results":false},{"nct_id":"NCT04742374","title":"Effects of Single Plasma Exchange and Double Filtration Plasmapheresis (DFPP) on Peripheral Lymphocyte Phenotypes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nīmes","has_results":false}],"total":15},"guidelines":[],"source":"Drug Landscape verified database"}